AnaptysBio is a clinical stage biotechnology company developing antibody product candidates. Etokimab, the company's anti-IL-33 antibody drug candidate, inhibits the activity of the interleukin-33 cytokine that is applicable to the treatment of atopic inflammatory disorders, such as moderate-to-severe atopic dermatitis, eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and potentially other allergic conditions. ANB019 inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases including generalized pustular psoriasis and palmoplantar pustulosis. The company's wholly-owned pipeline includes anti-inflammatory checkpoint receptor modulator antibodies.

Dorchester Minerals is engaged in the acquisition, ownership and administration of Royalty Properties and Net Profits Interests (NPIs). The Royalty Properties consist of producing and nonproducing mineral, royalty, overriding royalty, net profits, and leasehold interests located in several counties and parishes in several states. The NPIs represent net profits overriding royalty interests in various properties owned by the operating partnership. The company's general partner is Dorchester Minerals Management LP, which is managed by its general partner, Dorchester Minerals Management GP LLC.

HC2 Holdings is a holding company. Through its subsidiaries, the company operates in several segments including: Construction, which is a modeler, detailer, fabricator and erector of structural steel and heavy steel plate; Marine Services, which provides engineering and underwater services on submarine cables; Energy, which designs, builds, owns, acquires, operates and maintains compressed natural gas fueling stations for transportation vehicles; Telecommunications, which operates a telecommunications business including a network of direct routes and provides voice communication services; and Insurance, which provides long-term care, life, annuity, and other accident and health coverage.

NeuBase Therapeutics is a biotechnology company focused on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The company is developing antisense oligonucleotide therapies using its modular PATrOL? platform. The company's PATrOL?-enabled therapies act by binding to the mutant pre-RNA or messenger RNA primary sequence (or secondary or tertiary conformations) to prevent translation by ribosomes into mutant proteins or otherwise eliminate a pathogenic feature of the mutant transcript. The company's product pipeline comprised of NT0100 Program and NT0200 Program.

Penns Woods Bancorp is a bank holding company. Through its subsidiaries, Jersey Shore State Bank (JSSB) and Luzerne Bank (collectively, the Banks), the company is engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. The Banks provide insurance, securities brokerage services, annuity and mutual fund investment products, and financial planning through JSSB's subsidiary, The M Group, Inc. Services provided by the Banks include accepting time, demand and savings deposits including Super NOW accounts, money market accounts, and fixed rate certificates of deposit.

Premier Financial Bancorp is a multi-bank holding company and financial holding company. Through its subsidiaries (the Banks), Citizens Deposit Bank and Trust, Inc. and Premier Bank, Inc., the company provides a range of retail and commercial banking services, including commercial, real estate, agricultural and consumer lending; depository and funds transfer services; collections; safe deposit boxes; cash management services; and other services for both individuals and businesses. The Banks' range of deposit services includes checking accounts, NOW accounts, savings accounts, money market accounts, club accounts, individual retirement accounts, certificates of deposit and overdraft protection.

Texas Capital Bancshares is a bank holding company. Through its subsidiary, Texas Capital Bank, National Association, the company serves commercial businesses and professionals and entrepreneurs located in Texas as well as operates several lines of business serving a regional or national clientele of commercial borrowers. The company is a lender, with most of its loans held for investment, excluding mortgage finance loans and other national lines of business, being made to businesses headquartered or with operations in Texas. The company's business deposit products include commercial checking accounts, lockbox accounts, cash concentration accounts and other treasury management services, including online banking.